NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (Nasdaq: SDIX) will present recent data and case histories on the application of SDI’s proprietary antibody technology at the upcoming 30th Annual Meeting of the Society of Biochemistry and Molecular Biology in Yokohama, Japan. The presentation will be held at 3:00 p.m., Monday, December 10, 2007, at the Intercontinental Yokohama Grand Hotel.
